BerandaCAMX • STO
add
Camurus AB
Tutup sebelumnya
kr 689,50
Rentang hari
kr 685,00 - kr 696,00
Rentang tahun
kr 483,80 - kr 754,50
Kapitalisasi pasar
41,23Â M SEK
Volume Rata-Rata
119,04Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (SEK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 567,07Â jt | 18,24% |
Biaya operasional | 297,52Â jt | -2,21% |
Penghasilan bersih | 192,64Â jt | 48,93% |
Margin laba bersih | 33,97 | 25,95% |
Penghasilan per saham | 3,19 | 47,69% |
EBITDA | 236,64Â jt | 62,61% |
Tarif pajak efektif | 21,46% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,51Â M | 27,75% |
Total aset | 4,63Â M | 29,73% |
Total liabilitas | 510,02Â jt | 12,29% |
Total ekuitas | 4,12 M | — |
Saham yang beredar | 59,61 jt | — |
Harga terhadap nilai buku | 9,98 | — |
Tingkat pengembalian aset | 12,72% | — |
Tingkat pengembalian modal | 14,04% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 192,64Â jt | 48,93% |
Kas dari operasi | 160,46Â jt | 7,21% |
Kas dari investasi | -31,18Â jt | -425,92% |
Kas dari pembiayaan | 39,36Â jt | -7,37% |
Perubahan kas bersih | 167,29Â jt | -9,15% |
Arus kas bebas | 17,16Â jt | -72,69% |
Tentang
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Didirikan
1991
Situs
Karyawan
280
